Skip to main content

Biological treatment in times of COVID-19

Biological treatment in times of COVID-19




The confinement and social distance to which the current pandemic has forced us has brought about some concerns for patients with chronic diseases , such as psoriasis. Many of them are related to the biological treatments indicated for this pathology and for psoriatic arthritis, among other diseases, so it is essential to always go to safe sources to find reliable information about COVID-19 and psoriasis .

One of the main and very important doubts is whether or not to maintain treatment with a biological drug. to this day, there is no existing scientific evidence that treatment should be abandoned. This is also recommended by scientific societies : continue treatment if there are no symptoms compatible with the new coronavirus infection to continue controlling psoriasis . "

It also points out that it has not been shown that by receiving a biological treatment there are more possibilities of contracting the new SARS-CoV-2 virus, so the use of biological medication should be maintained as it had been done until before the pandemic, unless your doctor recommends otherwise for a specific reason.

In the event that a person develops symptoms compatible with the infection by the new coronavirus, Dr. González Cantero points out that it will be the dermatologist who will indicate how long the treatment should be delayed, as well as when to resume the routine with the biological drug. In any case, the recommendation is clear: " contact your dermatologist so that he can individualize your treatment . "

Manifestations on the skin

In relation to the skin, as Dr. Álvaro González Cantero clarifies, the new coronavirus can also cause skin manifestations in those infected by the virus. There are enough cases and enough evidence to take them into account. 

" The most curious skin lesions that have been related to the coronavirus are chilblains-type lesions on the fingers and toes, reddish and swollen, which -on occasions- even opened and formed a wound," says the dermatologist. These lesions have been seen, mainly, in children and young people and it is believed that they develop in the asymptomatic phase, so, in the opinion of the specialist, they should not be too worrying.

Other lesions that have been seen in people infected by SARS-CoV-2 are small vesicles throughout the body , some similar to chickenpox; and other urticaria-like patterns with itchy welts; or even rashes, that is, something similar to an allergic reaction, sums up the doctor.

His recommendation for these injuries is to monitor them, observe if there are other symptoms and always consult a dermatologist .

Comments

Popular posts from this blog

Testing delay increases COVID-19 cases in Honduras, according to microbiologists

Testing delay increases COVID-19 cases in Honduras, according to microbiologists The spokeswoman for the Honduran College of Microbiologists and Clinical Chemists, Miriam Aguilera, warned this day about the massive spread of COVID-19 by those asymptomatic patients who have been in contact with those who are awaiting the result of their test. "Only the Central District could be pulsing with more than 30 thousand positive cases and around 50 thousand cases nationwide, most of them asymptomatic that are infecting other people," he said.  Unofficial figures indicate that there are about seven thousand tests that are pending processing at the National Virology Laboratory, with an average delay of 10 days, of which the percentage of positivity would be higher than 71 percent. “We have a very high number of pending samples;  of these, we calculate approximately 5,000 positives, and if we count that three to five people are infected for each one, we could then speak of a very high nu...

When and how would the Covid-19 vaccine be distributed?

  Reuters -   Pfizer Inc with its partner BioNTech SE and Moderna Inc have released test data showing its  Covid-19 vaccines are 95% effective at preventing the disease  , while AstraZeneca Plc announced this week that its vaccine could be up to 90%. If regulators approve any of the vaccines in the next few weeks, the companies have said  distribution could begin almost immediately  , with governments around the world deciding who gets it and in what order.  The following is a summary of the process: WHEN WILL COMPANIES RELEASE A VACCINE? Pfizer, Moderna and AstraZeneca have already started manufacturing their vaccines.  Pfizer said this year it will have enough to inoculate 25 million people;  Moderna will have doses for 10 million people  and AstraZeneca for more than 100 million. The US Department of Defense and the Centers for Disease Control and Prevention ( CDC ) will manage the distribution in that country, probably starting in m...

What is the Coronavirus?

What is the Coronavirus? Due to the expansion of the  Coronavirus or COVID-19  in more than 150 countries, the   World Health Organization (WHO)  officially declared it a pandemic last March.  While many experts search for a cure or vaccine for this disease, current efforts have focused on declaring mandatory social isolation, putting the world economy on hold. In addition, the early detection of positive cases is sought, in order to isolate them and initiate appropriate treatment, seeking to save the greatest number of lives. Today, there are two methods that allow us to confirm if a person is infected with  COVID-19  ,  rapid  and molecular  tests  , each with its own characteristics and advantages. What is the Coronavirus or COVID-19? COVID-19  stands for  new coronavirus of 2019  , and it is a respiratory infection caused by the new coronavirus SARS-CoV-2.  The term "new coronavirus" simply means that it is a...
Biological treatment in times of COVID-19